STERIS Acquired Xodus Medical for $2.1 Billion
The healthcare company has announced a definitive agreement to purchase Xodus Medical to expand its operating room offerings.
Updated on Oct. 12, 2026 in Healthcare
Live Poll
Do you trust that further consolidation of medical device companies improves the safety of your care?
STERIS Corporation has signed a definitive agreement to acquire Xodus Medical in a deal valued at $2.1 billion. The transaction is expected to close by the end of 2026.
Why it matters
The acquisition allows STERIS to integrate a new portfolio of operating room consumables into its existing healthcare product offerings. This strategic move is expected to bolster top-line growth and adjusted earnings for the company.
Xodus Medical reported anticipated 2026 annual revenue of approximately $245 million and adjusted EBIT of roughly $135 million. The deal includes a potential performance-based earnout consideration of up to $150 million.
The players
STERIS Corporation
STERIS is a provider of infection prevention and other procedural products and services for healthcare and other industries.
Xodus Medical
Xodus Medical is a developer and manufacturer of medical devices for the operating room based in Pennsylvania.
The details
STERIS plans to finance the acquisition primarily through debt. The deal adds Xodus Medical's specialized consumables to the STERIS product line, building on the company founded in 1993 near Pittsburgh.
Timeline
Xodus Medical was founded in 1993.
The acquisition agreement was announced on October 12, 2026.
The acquisition is expected to close by December 31, 2026.
Performance targets for the potential $150 million earnout are based on 2028 results.
Market Landscape
This move reflects a broader trend of industry consolidation where major healthcare players acquire specialized manufacturers to enhance their product portfolios. STERIS aims to strengthen its market position against competitors by integrating Xodus Medical's operating room consumables.
The acquisition primarily affects the internal supply chains of healthcare providers who purchase operating room consumables. Customers can expect potential changes to product availability or service integration as STERIS incorporates the Xodus Medical line.
The takeaway
Healthcare providers should monitor how the integration of Xodus Medical products affects the procurement of surgical consumables. This acquisition marks a significant expansion for STERIS within the specialized operating room market.
Further reading
For more on industry shifts, visit the Healthcare section.
Live Poll
Do you trust that further consolidation of medical device companies improves the safety of your care?
